摘要
背景:癌症是全球主要的死亡原因之一,并且由于人口逐渐老龄化,未来几年它的患病率会更高。肿瘤学纳米载体的发展为抗击这种可怕的疾病提供了新的希望。 目的:在科学文献报道的不同类型的纳米粒子中,介孔二氧化硅纳米粒子(MSNs)由于其固有的性质如许多不同药物的高负载能力,优异的生物相容性和易于官能化而是非常有前景的材料。 结果:该综述介绍了与开发用于抗肿瘤治疗的介孔二氧化硅纳米载体有关的现有技术,特别关注有针对性的MSN,其能够选择性地破坏肿瘤细胞,减少健康人的副伤害,以及靶向肿瘤的基本原理组织和细胞。 结论:由于MSN独特的性质,例如优异的生物相容性,高负载能力,稳定性,易于生产和存在多种生物有机部分官能化策略,因此MSN在抗肿瘤治疗中的药物递送应用中构成了有前途的纳米材料。在未来几年,这种材料的巧妙应用将为治疗这种复杂疾病提供新的替代方法。
关键词: 纳米医学,靶向纳米载体,纳米肿瘤学,介孔二氧化硅纳米粒子,癌症,纳米粒子
图形摘要
Current Drug Targets
Title:Targeted Mesoporous Silica Nanocarriers in Oncology
Volume: 19 Issue: 3
关键词: 纳米医学,靶向纳米载体,纳米肿瘤学,介孔二氧化硅纳米粒子,癌症,纳米粒子
摘要: Background: Cancer is one of the major leading causes of death worldwide and its prevalence will be higher in the coming years due to the progressive aging of the population. The development of nanocarriers in oncology has provided a new hope in the fight against this terrible disease.
Objective: Among the different types of nanoparticles which have been reported in the scientific literature, mesoporous silica nanoparticles (MSNs) are very promising materials due to their inherent properties such as high loading capacity of many different drugs, excellent biocompatibility and easy functionalization.
Results: This review presents the current state of the art related to the development of mesoporous silica nanocarriers for antitumoral therapy paying special attention on targeted MSN able to selectively destroy tumoral cells, reducing the side damage in healthy ones, and the basic principles of targeting tumoral tissues and cells.
Conclusions: MSNs constitute a promising nanomaterial for drug delivery applications in antitumoral therapy as a consequence of its unique properties such as excellent biocompatibility, high loading capacity, robustness, easy production and existence of multiple strategies for their functionalization with a myriad of bio-organic moieties. In the coming years, the clever application of this material would provide novel alternatives for the treatment of this complex disease.
Export Options
About this article
Cite this article as:
Targeted Mesoporous Silica Nanocarriers in Oncology, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160603023037
DOI https://dx.doi.org/10.2174/1389450117666160603023037 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers